Molecular Basis of Tousled-Like Kinase 2 Activation
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Molekulare Pathologie Und Embryologie Von Hoxd13- Assoziierten Fehlbildungen Der Extremitäten
Molekulare Pathologie und Embryologie von Hoxd13- assoziierten Fehlbildungen der Extremitäten Dissertation zur Erlangung des akademischen Grades des Doktors der Naturwissenschaften (Dr. rer. nat.) eingereicht im Fachbereich Biologie, Chemie, Pharmazie der Freien Universität Berlin vorgelegt von Pia Bianca Kuss aus Krefeld März 2009 Die vorliegende Arbeit wurde im Zeitraum November 2004 bis März 2009 am Max-Planck-Institut für Molekulare Genetik unter der Leitung von Prof. Dr. Mundlos angefertigt. 1. Gutachter: Prof. Dr. Stefan Mundlos Max-Planck-Institut für molekulare Genetik Ihnestr. 73, 14195 Berlin Tel. 030 8413 1449 E-Mail: [email protected] 2. Gutachterin: Prof. Dr. Petra Knaus Institut für Biochemie Freie Universität Berlin Thielallee 63, 14195 Berlin Tel. 030 838 52935 E-Mail: [email protected] Disputation am : 03. Juni 2009 Hoffnung ist nicht die Überzeugung dass etwas gut ausgeht, sondern die Gewissheit, dass etwas Sinn hat, egal wie es ausgeht. V. Havel Selbstständigkeitserklärung Hiermit erkläre ich, dass ich die vorliegende Arbeit selbst angefertigt und keine anderen, als die hier angegebenen Hilfsmittel verwendet habe. Ich versichere, dass ich diese Arbeit weder in dieser noch in einer anderen Form bei einer anderen Prüfungsbehörde eingereicht habe. Berlin, den 20. März 2009 --------------------------------------- Pia Kuss Danke! Entgegen der akademischen Regeln gilt mein herzlichster Dank in allererster Linie meinem Vater und meinem Bruder Philipp. Ohne meine Familie wäre ich nicht der Mensch der ich bin, und schon gar nicht an dem Punkt, an dem ich nun bin. Danke für Eure Unterstützung, Euer Vertrauen und Eure Zuneigung...und dafür, dass ich meinen Weg weiter gehen konnte. Ich durfte erleben und lernen, dass Zusammenhalten das Wichtigste im Leben ist. -
Regulation of Oxidized Base Damage Repair by Chromatin Assembly Factor 1 Subunit a Chunying Yang1,*,†, Shiladitya Sengupta1,2,*,†, Pavana M
Published online 27 October 2016 Nucleic Acids Research, 2017, Vol. 45, No. 2 739–748 doi: 10.1093/nar/gkw1024 Regulation of oxidized base damage repair by chromatin assembly factor 1 subunit A Chunying Yang1,*,†, Shiladitya Sengupta1,2,*,†, Pavana M. Hegde1,JoyMitra1, Shuai Jiang3, Brooke Holey3, Altaf H. Sarker3, Miaw-Sheue Tsai3, Muralidhar L. Hegde1,2,4 and Sankar Mitra1,2,* 1Department of Radiation Oncology, Houston Methodist Research Institute, Houston, TX 77030, USA, 2Weill Cornell Medical College, Cornell University, New York, NY 10065, USA, 3Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA 94720, USA and 4Houston Methodist Neurological Institute, Houston, TX 77030, USA Received March 23, 2016; Revised October 13, 2016; Editorial Decision October 17, 2016; Accepted October 19, 2016 ABSTRACT INTRODUCTION Reactive oxygen species (ROS), generated both en- ROS, continuously generated in mammalian cells both en- dogenously and in response to exogenous stress, in- dogenously and by environmental genotoxicants, induce duce point mutations by mis-replication of oxidized various genomic lesions, including oxidized bases, abasic bases and other lesions in the genome. Repair of (AP) sites and single-strand breaks (SSBs). If unrepaired or these lesions via base excision repair (BER) pathway mis-repaired, DNA lesions would cause mutations which may lead to cytotoxicity and cell death and also carcino- maintains genomic fidelity. Regulation of the BER genic transformation (1). The base excision repair (BER) pathway for mutagenic oxidized bases, initiated by pathway, responsible for repair of oxidized base lesions NEIL1 and other DNA glycosylases at the chromatin which contribute to drug/radiation sensitivity is highly con- level remains unexplored. -
Differential Requirements for Tousled-Like Kinases 1 and 2 in Mammalian Development
Cell Death and Differentiation (2017) 24, 1872–1885 & 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved 1350-9047/17 www.nature.com/cdd Differential requirements for Tousled-like kinases 1 and 2 in mammalian development Sandra Segura-Bayona1,8, Philip A Knobel1,8, Helena González-Burón1,8, Sameh A Youssef2,3, Aida Peña-Blanco1, Étienne Coyaud4,5, Teresa López-Rovira1, Katrin Rein1, Lluís Palenzuela1, Julien Colombelli1, Stephen Forrow1, Brian Raught4,5, Anja Groth6, Alain de Bruin2,7 and Travis H Stracker*,1 The regulation of chromatin structure is critical for a wide range of essential cellular processes. The Tousled-like kinases, TLK1 and TLK2, regulate ASF1, a histone H3/H4 chaperone, and likely other substrates, and their activity has been implicated in transcription, DNA replication, DNA repair, RNA interference, cell cycle progression, viral latency, chromosome segregation and mitosis. However, little is known about the functions of TLK activity in vivo or the relative functions of the highly similar TLK1 and TLK2 in any cell type. To begin to address this, we have generated Tlk1- and Tlk2-deficient mice. We found that while TLK1 was dispensable for murine viability, TLK2 loss led to late embryonic lethality because of placental failure. TLK2 was required for normal trophoblast differentiation and the phosphorylation of ASF1 was reduced in placentas lacking TLK2. Conditional bypass of the placental phenotype allowed the generation of apparently healthy Tlk2-deficient mice, while only the depletion of both TLK1 and TLK2 led to extensive genomic instability, indicating that both activities contribute to genome maintenance. Our data identifies a specific role for TLK2 in placental function during mammalian development and suggests that TLK1 and TLK2 have largely redundant roles in genome maintenance. -
Aneuploidy: Using Genetic Instability to Preserve a Haploid Genome?
Health Science Campus FINAL APPROVAL OF DISSERTATION Doctor of Philosophy in Biomedical Science (Cancer Biology) Aneuploidy: Using genetic instability to preserve a haploid genome? Submitted by: Ramona Ramdath In partial fulfillment of the requirements for the degree of Doctor of Philosophy in Biomedical Science Examination Committee Signature/Date Major Advisor: David Allison, M.D., Ph.D. Academic James Trempe, Ph.D. Advisory Committee: David Giovanucci, Ph.D. Randall Ruch, Ph.D. Ronald Mellgren, Ph.D. Senior Associate Dean College of Graduate Studies Michael S. Bisesi, Ph.D. Date of Defense: April 10, 2009 Aneuploidy: Using genetic instability to preserve a haploid genome? Ramona Ramdath University of Toledo, Health Science Campus 2009 Dedication I dedicate this dissertation to my grandfather who died of lung cancer two years ago, but who always instilled in us the value and importance of education. And to my mom and sister, both of whom have been pillars of support and stimulating conversations. To my sister, Rehanna, especially- I hope this inspires you to achieve all that you want to in life, academically and otherwise. ii Acknowledgements As we go through these academic journeys, there are so many along the way that make an impact not only on our work, but on our lives as well, and I would like to say a heartfelt thank you to all of those people: My Committee members- Dr. James Trempe, Dr. David Giovanucchi, Dr. Ronald Mellgren and Dr. Randall Ruch for their guidance, suggestions, support and confidence in me. My major advisor- Dr. David Allison, for his constructive criticism and positive reinforcement. -
Identification of a Recurrent Microdeletion at 17Q23.1Q23.2
REPORT Identification of a Recurrent Microdeletion at 17q23.1q23.2 Flanked by Segmental Duplications Associated with Heart Defects and Limb Abnormalities Blake C. Ballif,1,* Aaron Theisen,1 Jill A. Rosenfeld,1 Ryan N. Traylor,1 Julie Gastier-Foster,2,3,4 Devon Lamb Thrush,2,4 Caroline Astbury,2,4 Dennis Bartholomew,4,5 Kim L. McBride,4,6 Robert E. Pyatt,2,3 Kate Shane,4,5 Wendy E. Smith,7 Valerie Banks,7 William B. Gallentine,8 Pamela Brock,9 M. Katharine Rudd,10 Margaret P. Adam,10 Julia A. Keene,10 John A. Phillips III,11 Jean P. Pfotenhauer,12 Gordon C. Gowans,9 Pawel Stankiewicz,13,14 Bassem A. Bejjani,1 and Lisa G. Shaffer1 Segmental duplications, which comprise ~5%–10% of the human genome, are known to mediate medically relevant deletions, duplications, and inversions through nonallelic homologous recombination (NAHR) and have been suggested to be hot spots in chromosome evolution and human genomic instability. We report seven individuals with microdeletions at 17q23.1q23.2, identified by microarray-based comparative genomic hybridization (aCGH). Six of the seven deletions are ~2.2 Mb in size and flanked by large segmental duplications of >98% sequence identity and in the same orientation. One of the deletions is ~2.8 Mb in size and is flanked on the distal side by a segmental duplication, whereas the proximal breakpoint falls between segmental duplications. These character- istics suggest that NAHR mediated six out of seven of these rearrangements. These individuals have common features, including mild to moderate developmental delay (particularly speech delay), microcephaly, postnatal growth retardation, heart defects, and hand, foot, and limb abnormalities. -
A Chromosome Level Genome of Astyanax Mexicanus Surface Fish for Comparing Population
bioRxiv preprint doi: https://doi.org/10.1101/2020.07.06.189654; this version posted July 6, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Title 2 A chromosome level genome of Astyanax mexicanus surface fish for comparing population- 3 specific genetic differences contributing to trait evolution. 4 5 Authors 6 Wesley C. Warren1, Tyler E. Boggs2, Richard Borowsky3, Brian M. Carlson4, Estephany 7 Ferrufino5, Joshua B. Gross2, LaDeana Hillier6, Zhilian Hu7, Alex C. Keene8, Alexander Kenzior9, 8 Johanna E. Kowalko5, Chad Tomlinson10, Milinn Kremitzki10, Madeleine E. Lemieux11, Tina 9 Graves-Lindsay10, Suzanne E. McGaugh12, Jeff T. Miller12, Mathilda Mommersteeg7, Rachel L. 10 Moran12, Robert Peuß9, Edward Rice1, Misty R. Riddle13, Itzel Sifuentes-Romero5, Bethany A. 11 Stanhope5,8, Clifford J. Tabin13, Sunishka Thakur5, Yamamoto Yoshiyuki14, Nicolas Rohner9,15 12 13 Authors for correspondence: Wesley C. Warren ([email protected]), Nicolas Rohner 14 ([email protected]) 15 16 Affiliation 17 1Department of Animal Sciences, Department of Surgery, Institute for Data Science and 18 Informatics, University of Missouri, Bond Life Sciences Center, Columbia, MO 19 2 Department of Biological Sciences, University of Cincinnati, Cincinnati, OH 20 3 Department of Biology, New York University, New York, NY 21 4 Department of Biology, The College of Wooster, Wooster, OH 22 5 Harriet L. Wilkes Honors College, Florida Atlantic University, Jupiter FL 23 6 Department of Genome Sciences, University of Washington, Seattle, WA 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.07.06.189654; this version posted July 6, 2020. -
TLK2 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap8102c
10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 TLK2 Antibody (Center) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP8102c Specification TLK2 Antibody (Center) - Product Information Application WB,E Primary Accession Q86UE8 Other Accession Q9UKI7 Reactivity Human, Mouse Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Antigen Region 141-171 TLK2 Antibody (Center) - Additional Information Western blot analysis of anti-TLK2 Antibody Gene ID 11011 (Center) (Cat.#AP8102c) in mouse testis tissue lysates (35ug/lane).TLK2(arrow) was Other Names detected using the purified Pab. Serine/threonine-protein kinase tousled-like 2, HsHPK, PKU-alpha, Tousled-like kinase 2, TLK2 Target/Specificity This TLK2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 141-171 amino acids from the Central region of human TLK2. Dilution WB~~1:1000 Format Purified polyclonal antibody supplied in PBS TLK2 Antibody (K155) (Cat. #AP8102c) with 0.09% (W/V) sodium azide. This western blot analysis in Y79 cell line lysates antibody is prepared by Saturated (35ug/lane).This demonstrates the TLK2 Ammonium Sulfate (SAS) precipitation antibody detected the TLK2 protein (arrow). followed by dialysis against PBS. Storage TLK2 Antibody (Center) - Background Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw TLK2, a member of the Ser/Thr protein kinase cycles. family, is rapidly and transiently inhibited by phosphorylation following the generation of Precautions DNA double-stranded breaks during S-phase. TLK2 Antibody (Center) is for research use This is cell cycle checkpoint and ATM-pathway only and not for use in diagnostic or dependent and appears to regulate processes therapeutic procedures. -
Induce Latent/Quiescent HSV-1 Genomes
Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis Camille Cohen, Armelle Corpet, Simon Roubille, Mohamed Maroui, Nolwenn Poccardi, Antoine Rousseau, Constance Kleijwegt, Olivier Binda, Pascale Texier, Nancy Sawtell, et al. To cite this version: Camille Cohen, Armelle Corpet, Simon Roubille, Mohamed Maroui, Nolwenn Poccardi, et al.. Promye- locytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatiniza- tion through a PML NB/Histone H3.3/H3.3 Chaperone Axis. PLoS Pathogens, Public Library of Science, 2018, 14 (9), pp.e1007313. 10.1371/journal.ppat.1007313. inserm-02167220 HAL Id: inserm-02167220 https://www.hal.inserm.fr/inserm-02167220 Submitted on 27 Jun 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. RESEARCH ARTICLE Promyelocytic leukemia (PML) nuclear bodies (NBs) induce latent/quiescent HSV-1 genomes chromatinization through a PML NB/Histone H3.3/H3.3 Chaperone Axis Camille Cohen1, Armelle Corpet1, Simon -
Histone H3.3 and Its Proteolytically Processed Form Drive a Cellular Senescence Programme
ARTICLE Received 21 Mar 2014 | Accepted 9 Sep 2014 | Published 14 Nov 2014 DOI: 10.1038/ncomms6210 Histone H3.3 and its proteolytically processed form drive a cellular senescence programme Luis F. Duarte1,2,3, Andrew R.J. Young4, Zichen Wang3,5, Hsan-Au Wu1,3, Taniya Panda1,2, Yan Kou3,5, Avnish Kapoor1,2,w, Dan Hasson1,2, Nicholas R. Mills1,2, Avi Ma’ayan5, Masashi Narita4 & Emily Bernstein1,2 The process of cellular senescence generates a repressive chromatin environment, however, the role of histone variants and histone proteolytic cleavage in senescence remains unclear. Here, using models of oncogene-induced and replicative senescence, we report novel histone H3 tail cleavage events mediated by the protease Cathepsin L. We find that cleaved forms of H3 are nucleosomal and the histone variant H3.3 is the preferred cleaved form of H3. Ectopic expression of H3.3 and its cleavage product (H3.3cs1), which lacks the first 21 amino acids of the H3 tail, is sufficient to induce senescence. Further, H3.3cs1 chromatin incorporation is mediated by the HUCA histone chaperone complex. Genome-wide transcriptional profiling revealed that H3.3cs1 facilitates transcriptional silencing of cell cycle regulators including RB/E2F target genes, likely via the permanent removal of H3K4me3. Collectively, our study identifies histone H3.3 and its proteolytically processed forms as key regulators of cellular senescence. 1 Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, New York 10029, USA. 2 Department of Dermatology, Icahn School of Medicine at Mount Sinai, One Gustave L. -
Research2007herschkowitzetvolume Al
Open Access Research2007HerschkowitzetVolume al. 8, Issue 5, Article R76 Identification of conserved gene expression features between comment murine mammary carcinoma models and human breast tumors Jason I Herschkowitz¤*†, Karl Simin¤‡, Victor J Weigman§, Igor Mikaelian¶, Jerry Usary*¥, Zhiyuan Hu*¥, Karen E Rasmussen*¥, Laundette P Jones#, Shahin Assefnia#, Subhashini Chandrasekharan¥, Michael G Backlund†, Yuzhi Yin#, Andrey I Khramtsov**, Roy Bastein††, John Quackenbush††, Robert I Glazer#, Powel H Brown‡‡, Jeffrey E Green§§, Levy Kopelovich, reviews Priscilla A Furth#, Juan P Palazzo, Olufunmilayo I Olopade, Philip S Bernard††, Gary A Churchill¶, Terry Van Dyke*¥ and Charles M Perou*¥ Addresses: *Lineberger Comprehensive Cancer Center. †Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ‡Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA. reports §Department of Biology and Program in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ¶The Jackson Laboratory, Bar Harbor, ME 04609, USA. ¥Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. #Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. **Department of Pathology, University of Chicago, Chicago, IL 60637, USA. ††Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. ‡‡Baylor College of Medicine, Houston, TX 77030, USA. §§Transgenic Oncogenesis Group, Laboratory of Cancer Biology and Genetics. Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, MD 20892, USA. Department of Pathology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Section of Hematology/Oncology, Department of Medicine, Committees on Genetics and Cancer Biology, University of Chicago, Chicago, IL 60637, USA. -
A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family
Rockefeller University Digital Commons @ RU Student Theses and Dissertations 2018 A High-Throughput Approach to Uncover Novel Roles of APOBEC2, a Functional Orphan of the AID/APOBEC Family Linda Molla Follow this and additional works at: https://digitalcommons.rockefeller.edu/ student_theses_and_dissertations Part of the Life Sciences Commons A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY A Thesis Presented to the Faculty of The Rockefeller University in Partial Fulfillment of the Requirements for the degree of Doctor of Philosophy by Linda Molla June 2018 © Copyright by Linda Molla 2018 A HIGH-THROUGHPUT APPROACH TO UNCOVER NOVEL ROLES OF APOBEC2, A FUNCTIONAL ORPHAN OF THE AID/APOBEC FAMILY Linda Molla, Ph.D. The Rockefeller University 2018 APOBEC2 is a member of the AID/APOBEC cytidine deaminase family of proteins. Unlike most of AID/APOBEC, however, APOBEC2’s function remains elusive. Previous research has implicated APOBEC2 in diverse organisms and cellular processes such as muscle biology (in Mus musculus), regeneration (in Danio rerio), and development (in Xenopus laevis). APOBEC2 has also been implicated in cancer. However the enzymatic activity, substrate or physiological target(s) of APOBEC2 are unknown. For this thesis, I have combined Next Generation Sequencing (NGS) techniques with state-of-the-art molecular biology to determine the physiological targets of APOBEC2. Using a cell culture muscle differentiation system, and RNA sequencing (RNA-Seq) by polyA capture, I demonstrated that unlike the AID/APOBEC family member APOBEC1, APOBEC2 is not an RNA editor. Using the same system combined with enhanced Reduced Representation Bisulfite Sequencing (eRRBS) analyses I showed that, unlike the AID/APOBEC family member AID, APOBEC2 does not act as a 5-methyl-C deaminase. -
The P53mh Algorithm and Its Application in Detecting P53-Responsive Genes
The p53MH algorithm and its application in detecting p53-responsive genes J. Hoh*†‡, S. Jin§†, T. Parrado*, J. Edington*, A. J. Levine§, and J. Ott* *Laboratories of Statistical Genetics and §Cancer Biology of The Rockefeller University, 1230 York Avenue, New York, NY 10021 Contributed by A. J. Levine, May 6, 2002 A computer algorithm, p53MH, was developed, which identifies overall binding likelihood is needed for a given gene of arbitrary putative p53 transcription factor DNA-binding sites on a genome- size. Three features have been implemented in an algorithm to wide scale with high power and versatility. With the sequences meet the above requirements: binding propensity plots, weighted from the human and mouse genomes, putative p53 DNA-binding scores, and statistical significance for most likely binding sites. elements were identified in a scan of 2,583 human genes and 1,713 This computer algorithm has been used to identify putative mouse orthologs based on the experimental data of el-Deiry et al. binding elements on a genomewide scale. The algorithm, [el-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W. & p53MH, uses an optimal scoring system as an indication of the Vogelstein, B. (1992) Nat. Genet. 1, 45–49] and Funk et al. [Funk, percent similarity to the consensus. It can simultaneously screen W. D., Pak, D. T., Karas, R. H., Wright, W. E. & Shay, J. W. (1992) Mol. thousands of genes for degenerate consensus sequences in the Cell. Biol. 12, 2866–2871] (http:͞͞linkage.rockefeller.edu͞p53). The course of only a few minutes. With this, based on the available p53 DNA-binding motif consists of a 10-bp palindrome and most annotated human sequence databases, a White Page-like direc- commonly a second related palindrome linked by a spacer region.